In France, pharmaceutical exports have experienced various trends over the past decade. In 2023, the value of pharmaceutical exports stood at $43.49 billion, showing a consistent upward trajectory since 2016 following dips in the earlier part of the decade. Year-on-year growth varied significantly from -14.19% in 2015 to a steady rise with a 3.96% increase recently. The Compound Annual Growth Rate (CAGR) has also shown a robust increase, standing at 4.75% over the past five years.

Forecasts indicate that by 2028, the pharmaceutical export market in France will reach $51.52 billion, with a forecasted five-year CAGR of 2.69%. The forecasted growth rate over these next years is expected to be 14.17%, suggesting a steady but moderate growth trend.

Future trends to watch for include:

Advancements in biotechnology and personalized medicine.
Expansion into emerging markets driven by increased healthcare demands.
Potential impacts of regulatory changes and trade policies within the EU and globally.